Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Marsh & McLennan Companies, Inc. (MRSH) vs Global X Uranium ETF (URA) Price & Performance

Marsh & McLennan Companies, Inc.Trade
Global X Uranium ETFTrade

Price performance (Past 24H)

Key statistics

Marsh & McLennan Companies, Inc. vs Global X Uranium ETF — how do they compare? Marsh & McLennan Companies, Inc. trades at $176.89 (market cap $84.39B), while Global X Uranium ETF trades at $46.65. The key difference: Marsh & McLennan Companies, Inc. pays a 2.24% dividend while Global X Uranium ETF pays none. Which is the better fit depends on your goals.

MRSHURA
Market Cap
$84.39B
Sector
FinancialsCommodities - Metals/Agriculture
52-Week High
$207.02$61.81
52-Week Low
$157.32$37.52
Enterprise Value
$105.07B
Dividend Yield
2.24%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Marsh & McLennan Companies, Inc.

Marsh & McLennan (MRSH) trades at $180.52, down 2.81% on the day, with a bullish technical signal despite recent weakness. The company shows solid fundamentals with revenue growth to $26.98B in 2025 and consistent earnings beats. Analyst consensus is a Buy with a $208.63 price target, though sentiment is mixed with 66.7% Hold ratings. Recent news highlights expansion in cyber protection services and insights on healthcare cost trends.

The outlook remains positive given strong profitability and strategic initiatives, but risks include economic sensitivity and competitive pressures. The stock offers upside to the consensus target, supported by institutional interest and stable cash flows, though high valuation multiples warrant caution amid market volatility.

Global X Uranium ETF

URA (Global X Uranium ETF) trades at $47.50, up 3.13% today, with strong bullish technical signals from moving averages. The ETF benefits from growing nuclear energy demand driven by AI power needs and government support, including recent $17.5 billion in U.S. reactor funding. However, key financial ratios remain unavailable, and the sector faces volatility from uranium price fluctuations and regulatory shifts.

Outlook remains positive due to structural tailwinds in nuclear energy, but investors should monitor uranium contract pricing and ETF expense ratios. Near-term resistance sits at $48-$50, with support at $45-$47. Risks include policy changes and miner concentration, though institutional interest in nuclear ETFs is rising.

Returns comparison

Trailing returns across standard periods

About Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).

Read more on MRSH

About Global X Uranium ETF

URA provides broad exposure to the global uranium industry and nuclear energy sector. Unlike pure-play mining funds, it includes companies involved in nuclear component production and infrastructure, with top 2026 holdings such as Cameco, Oklo, and Uranium Energy Corp.

Read more on URA